Bill · H.R. 9077· House(119-HR-9077)
Hormone Health Data and Research Act
- Introduced
- 5/29/2026
- Last activity
- 5/29/2026 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Hillary Scholten
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
This bill, known as the "Hormone Health Data and Research Act," directs specific federal actions regarding perimenopause. The Director of the National Institutes of Health is tasked with evaluating evidence regarding hormone level variability and baseline patterns in women before they experience perimenopause symptoms. Additionally, the Secretary of Health and Human Services, through the U.S. Preventive Services Task Force, must review evidence on the clinical utility of hormone testing. The goal is to determine if baseline hormone information helps in the diagnosis or management of perimenopause. Both entities are required to submit a report summarizing their findings and recommendations within 18 months.
Yes· 3 of 5
Would women be better off under this?+4
The bill seeks to improve the diagnosis and management of perimenopause through specialized clinical research.
Would people in middle age be better off under this?+3
The bill focuses on medical research for perimenopause, a health transition typically occurring in middle age.
Does this make health care easier to get in general?+3
The bill directs studies that may lead to better clinical guidance and management of perimenopause.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved understanding of hormonal changes: The NIH will evaluate evidence regarding how hormone levels vary and what baseline patterns exist before perimenopause symptoms begin (Section 2(a)). This could lead to better knowledge of how women's bodies change.
-
Better clinical management and diagnosis: The U.S. Preventive Services Task Force will review if hormone testing and baseline information can meaningfully inform the diagnosis or management of perimenopause (Section 2(b)). This could lead to clearer medical guidance for women experiencing these transitions.
-
Identification of future research needs: The required report will summarize findings and identify evidence gaps (Section 2(c)). This helps ensure that future research and clinical guidance are directed toward the most important areas for women's health.
Potential Negative Impacts for People
- No specific negative impacts are identified in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Women+4Good For Middle Aged+3
- Healthcare
- Improves Healthcare Access+3Increases Research Funding+2
- Social Issues And Justice
- Improves Gender Equality+3
- 5/29/2026
- Referred to the House Committee on Energy and Commerce.
- Introduced in House